Showing results (431-440 of 538) with videos related to
Sort By:
Pageof 54
Journal of the American College of Cardiology|December 2, 2017
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM TrialJonathan M Tobis, Andrew Charles, Stephen D Silberstein, et al.European Journal of Pharmacology|January 20, 2004
Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteriesAngelica Wackenfors, Malin Emilson, Richard Ingemansson, et al.Journal of Personalized Medicine|February 23, 2024
How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel ReviewFrederick Godley, John Meitzen, Hadas Nahman-Averbuch, et al.Clinical Science (London, England : 1979)|August 8, 2019
Pre-clinical effects of highly potent MEK1/2 inhibitors on rat cerebral vasculature after organ culture and subarachnoid haemorrhageSimon T Christensen, Kristian A Haanes, Stine Spray, et al.Cephalalgia : an International Journal of Headache|June 4, 2020
Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptorsKarin Warfvinge, Diana N Krause, Aida Maddahi, et al.The Journal of Headache and Pain|May 29, 2026
CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhageEmelie P Fungbrant, Jesper P Bömers, Philip V Reducha, et al.Vascular Pharmacology|February 14, 2017
Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteriesMajid Sheykhzade, Nilofar Amandi, Monica Vidal Pla, et al.Vascular Pharmacology|September 20, 2023
Heterogeneous vasomotor responses in segments from Göttingen Minipigs coronary, cerebral, and mesenteric artery: A comparative studyAnette Sams, Kristian Agmund Haanes, Anja Holm, et al.Headache|May 11, 2019
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialDavid Yarnitsky, David W Dodick, Brian M Grosberg, et al.The Journal of Headache and Pain|January 8, 2021
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trialsStephen D Silberstein, Joshua M Cohen, Ronghua Yang, et al.Pageof 54